Literature DB >> 2456344

Tumor necrosis factor and IFN induce a common set of proteins.

B Y Rubin1, S L Anderson, R M Lunn, N K Richardson, G R Hellermann, L J Smith, L J Old.   

Abstract

The treatment of cells with TNF or IFN results in the development of an antiviral state and in the induction of a common set of proteins with m.w. of 80,000, 67,000, and 56,000. The induction of the 80,000- and 56,000-Da proteins after TNF treatment is dependent on the synthesis of an intermediary protein, whereas the induction of the 67,000-Da protein appears to occur as a direct result of the TNF treatment. The effects of antibodies to IFN on the TNF-mediated effects have been evaluated and reveal that the incubation of TNF-treated cells with antibody to rIFN-beta 1 greatly reduces the antiviral effectiveness of the TNF treatment and blocks the ability of TNF to induce the 80,000-Da protein. Incubation with antibodies to either IFN-alpha or IFN-gamma failed to affect the TNF-mediated responses. Thus, the induction by TNF of each of the proteins is regulated differently and is mediated through both IFN-dependent and IFN-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456344

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Trypanosoma cruzi as an effective cancer antigen delivery vector.

Authors:  Caroline Junqueira; Luara I Santos; Bruno Galvão-Filho; Santuza M Teixeira; Flávia G Rodrigues; Wanderson D DaRocha; Egler Chiari; Achim A Jungbluth; Gerd Ritter; Sacha Gnjatic; Lloyd J Old; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-23       Impact factor: 11.205

3.  Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid.

Authors:  S M Hsu; P L Hsu
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

4.  Theiler's murine encephalomyelitis virus induces tumour necrosis factor-alpha in murine astrocyte cell cultures.

Authors:  A Sierra; N Rubio
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha.

Authors:  K Adachi; P Belser; H Bender; D Li; U Rodeck; E N Benveniste; D Woo; W H Schmiegel; D Herlyn
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes.

Authors:  A E Goldfeld; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

7.  Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

Authors:  T Fujita; L F Reis; N Watanabe; Y Kimura; T Taniguchi; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Role of the nitric oxide synthase pathway in inhibition of growth of interferon-sensitive and interferon-resistant Rickettsia prowazekii strains in L929 cells treated with tumor necrosis factor alpha and gamma interferon.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.

Authors:  J M Boss; S M Laster; L R Gooding
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

10.  Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.

Authors:  I C Oliveira; P J Sciavolino; T H Lee; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.